FDA inspection
Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.: FDA inspection ending Apr 11, 2025
FDA inspection 1269495 · No Action Indicated (NAI) · Nanning
Key facts
| Inspection ID | 1269495 |
|---|---|
| Firm | Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. |
| FEI number | 3004268442 |
| Address | 46 Wen Jiang Road, Chengxiangzhen Wumingxian |
| City | Nanning |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Apr 11, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data